Edition:
India

Supernus Pharmaceuticals Inc (SUPN.OQ)

SUPN.OQ on NASDAQ Stock Exchange Global Market

53.10USD
11:54pm IST
Change (% chg)

$0.40 (+0.76%)
Prev Close
$52.70
Open
$52.85
Day's High
$53.15
Day's Low
$52.20
Volume
65,623
Avg. Vol
217,754
52-wk High
$61.25
52-wk Low
$33.45

Chart for

About

Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company offers Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (extended-release topiramate), its two treatments for patients with epilepsy. In... (more)

Overall

Beta: 1.30
Market Cap(Mil.): $2,149.64
Shares Outstanding(Mil.): 50.70
Dividend: --
Yield (%): --

Financials

  SUPN.OQ Industry Sector
P/E (TTM): 21.31 30.93 32.76
EPS (TTM): 1.99 -- --
ROI: 50.40 15.07 14.61
ROE: 61.13 16.60 16.34

BRIEF-Supernus Pharma Reports Q1 Earnings Per Share $0.49

* SUPERNUS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RECORD QUARTERLY REVENUE

09 May 2018

BRIEF-Supernus Announces Pricing Of $350 Mln Private Offering Of 0.625 Pct Convertible Senior Notes

* SUPERNUS ANNOUNCES PRICING OF $350 MILLION PRIVATE OFFERING OF 0.625% CONVERTIBLE SENIOR NOTES

15 Mar 2018

BRIEF-Supernus Announces Proposed Private Offering Of $350 Million Of Convertible Senior Notes

* SUPERNUS ANNOUNCES PROPOSED PRIVATE OFFERING OF $350 MILLION OF CONVERTIBLE SENIOR NOTES

14 Mar 2018

BRIEF-Supernus Reports Q4 Earnings Per Share ‍$0.26​

* SUPERNUS ANNOUNCES RECORD FULL YEAR 2017 FINANCIAL RESULTS, EXCEEDING OPERATING EARNINGS GUIDANCE

28 Feb 2018

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $62.99 +1.22
AstraZeneca plc (AZN.L) 5,551.00 +84.00
Eli Lilly And Co (LLY.N) $89.85 +0.78
Shire PLC (SHP.L) 4,366.50 +42.50
Shire PLC (3159084.L) -- --
Smiths Group plc (SMIN.L) 1,749.50 +9.50

Earnings vs. Estimates